Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12R - Indexing scheme associated with subclasses , relating to micro-organisms › C12R 1 - Micro-organisms
Patents for C12R 1 - Micro-organisms (92,025)
05/1996
05/09/1996CA2203398A1 An enzyme with lipolytic activity
05/08/1996EP0710723A1 Cloning and expression of a gene encoding bryodin 1 from bryonia dioica
05/08/1996EP0710722A1 Genetic mechanisms of tumor suppression
05/08/1996EP0710719A1 Generation of xenogeneic antibodies
05/08/1996EP0710360A1 Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases
05/08/1996EP0710290A1 Method for precipitating natural avermectins
05/08/1996EP0710288A1 Adenoviral vectors for treatment of hemophilia
05/08/1996EP0710286A1 Methods and dna expression systems for over-expression of proteins in host cells
05/08/1996EP0710285A1 Analogues of an anti-thrombin polypeptide and process for their preparation
05/08/1996EP0710281A1 A method of producing a protein disulfide redox agent
05/08/1996EP0710280A1 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
05/08/1996EP0710252A1 Monoclonal antibodies to egg yolk immunoglobulins (igy)
05/08/1996EP0710248A1 Melanoma-inhibiting protein
05/08/1996EP0710244A1 Immunoreactive reagents employing monoamine oxidase
05/08/1996EP0710123A1 Adenovirus vectors for gene therapy sponsorship
05/08/1996EP0710110A1 Rapamycin conjugates and antibodies
05/08/1996EP0424473B1 Methods for identification of bacteria
05/08/1996EP0423198B1 Antibodies specific towards hiv 1 gp 48
05/08/1996EP0368966B1 Novel non-reverting shigella live vaccines
05/08/1996EP0328578B1 Antigen recognized by mca 16-88
05/08/1996CN1122139A Improved HCV diagnostic agents
05/08/1996CN1121971A A process for providing localized variation in the colour density of fabrics
05/08/1996CN1031759C Process for preparing monoclonal antibody specific to common determinant site of neutrophils and eosinophils
05/07/1996US5514792 Chemically modified succinoglycans and industrial compositions comprised thereof
05/07/1996US5514715 Amino cyclopentanecarboxylic acid, fungicide
05/07/1996US5514649 Animal growth regulators; treating gramnegative and grampositive bacterial infections
05/07/1996US5514648 Fungicidally active compounds
05/07/1996US5514599 Antibodies against highly conserved amino acid sequences of insulin a process for the preparation of these antibodies and the use thereof in immunoassays
05/07/1996US5514589 Chiral resolution of an intermediate in diltiazem synthesis using lipase PS immobilized with sucrose
05/07/1996US5514586 Plasmid vectors and GRAS microorganisms promoting ice nucleation
05/07/1996US5514585 Yeast processing system
05/07/1996US5514576 Gene expression, engineering; dna sequence
05/07/1996US5514544 Dna sequences for genetic engineering
05/07/1996US5514542 Methods for propagating retrovirus for use in antibody assays
05/07/1996US5514538 Bicarbonate assay and phosphoenolpyruvate carboxylase enzyme from hyphomicrobium
05/07/1996CA2058934C Processes for the recovery of microbially produced chymosin
05/07/1996CA1338310C Polycyclic peptide antibiotic and method for production thereof
05/07/1996CA1338309C Homologues of aprotinin produced from a recombinant host, process, expression vector and recombinant host therefor and pharmaceutical use thereof
05/02/1996WO1996012964A1 Receptor for a bacillus thuringiensis toxin
05/02/1996WO1996012818A1 Biological resolution of racemic indene oxide to (1s,2r)-indene oxide
05/02/1996WO1996012809A2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
05/02/1996WO1996012807A2 Hepatitis e virus antigens and uses therefor
05/02/1996WO1996012804A2 Recombinant dna
05/02/1996WO1996012801A1 Oral immunization with transgenic plants
05/02/1996WO1996012797A1 Production and use of human and plant methyltransferases
05/02/1996WO1996012796A1 Conditional transformation of genetically engineered cells
05/02/1996WO1996012790A1 Microbial synthesis of hiv protease inhibitors
05/02/1996WO1996012733A1 Major outer membrane protein cd of moraxella
05/02/1996WO1996012501A1 Human hypoxanthine-(guanine) phosphoribosyl transferase-2
05/02/1996WO1996012492A1 Microbial synthesis of hiv protease inhibitors
05/02/1996WO1996012406A1 Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents
05/02/1996WO1996009386A3 Allelic variation of the serotonin 5ht2c receptor
05/02/1996WO1996003997A3 Treatment of cancer using hsv mutant
05/02/1996WO1996003151A3 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy
05/02/1996WO1994025604A3 Steroid 21-hydroxylase fragments and assays using the same
05/02/1996CA2652992A1 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
05/02/1996CA2203265A1 Production and use of human and plant methyltransferases
05/02/1996CA2203016A1 Biological resolution of racemic indene oxide to (1s,2r)-indene oxide
05/02/1996CA2202130A1 Recombinant dna
05/02/1996CA2200869A1 Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents
05/02/1996CA2200427A1 Receptor for a bacillus thuringiensis toxin
05/01/1996EP0709464A2 Process for the enzymatic separation of enantiomers of racemic 2-oxotricyclo-2,2,1,03,5-heptan-7-carboxylic acids and esters thereof
05/01/1996EP0709461A1 Recombinant thermostable enzyme which forms non-reducing saccharide from reducing amylaceous saccharide
05/01/1996EP0709460A1 Coccidiosis poultry vaccine
05/01/1996EP0709459A2 Modified biological material
05/01/1996EP0709456A2 Microbial cholesterol-dehydrogenase, process for the preparation and use
05/01/1996EP0709455A1 Monoclonal antibody to human glicentin, hybridoma for producing said antibody and assay method for human glicentin using said antibody
05/01/1996EP0709397A1 p53as Protein and antibody therefor
05/01/1996EP0709396A1 Gamma T cell receptor and methods for detection
05/01/1996EP0708877A1 Method for repairing a combustion chamber assembly
05/01/1996EP0708834A1 FORMATION OF AND METHODS FOR THE PRODUCTION OF LARGE $i(BACILLUS THURINGIENSIS) CRYSTALS WITH INCREASED PESTICIDAL ACTIVITY
05/01/1996EP0708833A1 Herpes simplex virus type-2 protease
05/01/1996EP0708832A1 Helicobacter pylori haemagglutinin/protease protein, nucleic acid encoding therefor and antibodies specific thereto
05/01/1996EP0708831A1 Density enhanced protein tyrosine phosphatases
05/01/1996EP0708830A1 $i(BACILLUS THURINGIENSIS) ISOLATES AND TOXINS
05/01/1996EP0708825A1 A fungal protein disulfide isomerase
05/01/1996EP0708824A1 An enzyme with acetyl esterase activity
05/01/1996EP0708655A1 Methods of using insulin-like growth factor binding proteins
05/01/1996EP0708653A1 Assay and reagents for identifying anti-proliferative agents
05/01/1996EP0708604A1 ASTAXANTHIN OVER-PRODUCING STRAINS OF $i(PHAFFIA RHODOZYMA), METHODS FOR THEIR CULTIVATION, AND THEIR USE IN ANIMAL FEEDS
05/01/1996EP0491031B1 Cdr grafted anti-cea antibodies and their production
05/01/1996EP0441917B1 Pokeweed antiviral protein - monoclonal antibody conjugates
05/01/1996CN1121734A A method of hydrolysing cholesterol esters by using a pseudomonas fragi cholesterolesterase
05/01/1996CN1121733A Integrative DNA segment comprising gene encoding insecticidal protein
05/01/1996CN1121732A A method for hydrolysing proteins
05/01/1996CN1121731A Viable bacteria
05/01/1996CN1121724A Extraction of cell-bound protein from bordetella
05/01/1996CA2161480A1 Monoclonal antibody to human glicentin, hybridoma for producing said antibody and assay method for human glicentin using said antibody
04/1996
04/30/1996US5512658 Pseudomonas exotoxins (PE) and conjugates thereof having lower animal toxicity with high cytocidal activity through substitution of positively charged amino acids
04/30/1996US5512550 Method for inhibiting angiogenesis with modified platelet factor-4 and cleaved platelet factor-4
04/30/1996US5512473 Max-interacting proteins and related molecules and methods
04/30/1996US5512468 Process of producing highly transformable bacterial cells and cells produced thereby
04/30/1996US5512460 Glia activating factor and its production
04/30/1996US5512459 Transpeptization by contacting peptide and addition unit with thrombin to cleave leaving unit from core at enzyme cleavage site
04/30/1996US5512457 Cytokine designated elk ligand
04/30/1996US5512455 Atrial natriuretic peptide receptor protein
04/30/1996US5512454 Enzymatic acylation of 3-hydroxymethyl cephalosporins
04/30/1996US5512443 Second generation monoclonal antibodies having binding specificity to TAG-72 and human carcinomas and methods for employing the same
04/30/1996US5512440 Heating with forced hot air in the absence of lysogenic agents
04/30/1996US5512421 Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors
1 ... 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 ... 921